|
Nusblat, Leora M; Carroll, Molly J; Roth, Charles M (2017) Crosstalk between M2 macrophages and glioma stem cells. Cell Oncol (Dordr) 40:471-482
|
|
Cataldo, A M; Hamilton, D J; Barnett, J L et al. (1996) Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J Neurosci 16:186-99
|
|
Mohan, P S; Nixon, R A (1995) Purification and properties of high molecular weight calpastatin from bovine brain. J Neurochem 64:859-66
|
|
Cataldo, A M; Barnett, J L; Berman, S A et al. (1995) Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron 14:671-80
|
|
Compaine, A; Schein, J D; Tabb, J S et al. (1995) Limited proteolytic processing of the mature form of cathepsin D in human and mouse brain: postmortem stability of enzyme structure and activity. Neurochem Int 27:385-96
|
|
Nixon, R A (1994) Neuronal degenerative mechanisms as clues to pathogenesis and treatment of Alzheimer's disease. Neurobiol Aging 15 Suppl 2:S61-5
|
|
Cataldo, A M; Hamilton, D J; Nixon, R A (1994) Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease. Brain Res 640:68-80
|
|
Burke, W J; Galvin, N J; Chung, H D et al. (1994) Degenerative changes in epinephrine tonic vasomotor neurons in Alzheimer's disease. Brain Res 661:35-42
|
|
Saito, K; Elce, J S; Hamos, J E et al. (1993) Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci U S A 90:2628-32
|
|
Saito, K; Nixon, R A (1993) Specificity of calcium-activated neutral proteinase (CANP) inhibitors for human mu CANP and mCANP. Neurochem Res 18:231-3
|
Showing the most recent 10 out of 21 publications
